Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

RomaniaBack to Romania

Clinical trials in Sibiu – page 5

55 clinical trials in Sibiu, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Sibiu at a glance
55
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

55 trials in Sibiu

Open in trial search

Lung neoplasm malignant

Not recruiting

Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Domvanalimab
  • Sponsor:AstraZeneca AB

Axial spondyloarthritis

Not recruiting

Study of Secukinumab for Maintaining Remission in Patients with Non-Radiographic Axial Spondyloarthritis

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Secukinumab
  • Sponsor:Novartis Pharma AG

Chronic myeloid leukaemia

Not recruiting

Study on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Nilotinib
  • Sponsor:Novartis Pharma AG

Diffuse large B-cell lymphoma+2

Not recruiting

Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Celgene Corp.

Non-small cell lung cancer metastatic

Not recruiting

Study of Adagrasib Dosing in Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C Mutation

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.

Plasma cell myeloma

Not recruiting

Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:Celgene Corp.

COVID-19

Not recruiting

Study on the Effectiveness and Safety of Bemnifosbuvir for High-Risk COVID-19 Patients

Registered drug
Countries:RomaniaRomania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nirmatrelvir
  • Sponsor:Atea Pharmaceuticals Inc.

Other cities in Romania

The busiest research cities in the country

All 65 cities in Romania

Clinical research in Sibiu

What the registry says about research in the country

01 Neurological Disorders

Innovative trials focusing on Myasthenia Gravis and various forms of Multiple Sclerosis, including studies evaluating new therapeutic approaches for disease management and symptom control.

  • Relapsing Multiple Sclerosis
  • Generalized Myasthenia Gravis
  • Episodic Migraine in Pediatrics

Several trials are investigating novel compounds to improve daily living activities and reduce disease progression.

02 Oncology Research

Comprehensive studies on various cancer types, with particular focus on Non-Small Cell Lung Cancer and Lymphoma treatments, including innovative combination therapies.

  • Large B-Cell Lymphoma
  • Chronic Myeloid Leukemia
  • Bladder Cancer
  • Early Breast Cancer

Advanced therapeutic approaches combining immunotherapy with standard treatments.

03 Mental Health Studies

Research initiatives addressing Major Depressive Disorder and Schizophrenia, with specialized focus on treatment-resistant cases and cognitive symptoms.

  • Depression with Anhedonia
  • Depression with Insomnia
  • Alzheimer's Disease Psychosis

Novel therapeutic approaches targeting specific symptoms and comorbidities.

Back to RomaniaAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.